News

16/05/2023

A study reveals how toxic proteins spread through the brain in Alzheimer’s disease.

A study co-led by researchers from the Neurobiology of Dementia group at the Research Institute of Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, published in the prestigious journal Neuron, of ...

10/05/2023

Sant Pau crea un nou programa transversal de recerca en Salut de la Dona i Gènere

L'Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau – IIB Sant Pau ha posat en marxa un nou programa transversal de recerca per fomentar la perspectiva de gènere en totes les seves à...

05/05/2023

GFAP, marcador plasmàtic clau per al futur diagnòstic de l’Alzheimer a la Síndrome de Down

Un estudi coliderat pel Dr. Daniel Alcolea, investigador de l'Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau – IIB Sant Pau i la Unitat de Memòria – Unitat Alzheimer-Down de l'Hosp...

04/05/2023

A study reveals the existence of different patterns of cognitive progression in Huntington’s disease

Huntington's disease is a hereditary neurodegenerative disease caused by a mutation in a gene, which severely affects the cognitive ability of those who suffer from it. Traditionally, the way in which...

03/05/2023

Sant Pau administrates a new CAR-T immunotherapy drug, self-produced, against B-cell lymphomas

The Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau has developed a new CAR-T 19 immunotherapy drug that has just begun to be administered, as part of a clinical trial, t...